AIP
ATYR

Ameritas Investment Partners’s aTyr Pharma ATYR Stock Holding History

Ameritas Investment Partners’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,881
Closed -$6.93K – 3353
2026
Q1 		$6.93K Hold
8,881
– – ﹤0.01% 2934
2025
Q4 		$6.96K Hold
8,881
– – ﹤0.01% 2983
2025
Q3 		$6.41K Hold
8,881
– – ﹤0.01% 3030
2025
Q2 		$45K Buy
+8,881
New +$34.9K ﹤0.01% 2251

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameritas Investment Partners's ATYR Position: Q2 2026 in Review

Ameritas Investment Partners sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 8,881 shares — an estimated $6.93K sold.

Ameritas Investment Partners first reported a position in ATYR in Q2 2025 and held it in 4 quarters. The position peaked at $45K in Q2 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Ameritas Investment Partners reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
  • Ameritas Investment Partners sold 8,881 aTyr Pharma shares in Q2 2026, an estimated $6.93K.
  • Ameritas Investment Partners first reported a position in aTyr Pharma in Q2 2025 and held it in 4 quarters.
  • Ameritas Investment Partners's aTyr Pharma position peaked at $45K in Q2 2025.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.